Mark L. Berch

Array ( [id] => 5374758 [patent_doc_number] => 20090312319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/503776 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 62792 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312319.pdf [firstpage_image] =>[orig_patent_app_number] => 12503776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760292 [patent_doc_number] => 08420813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines' [patent_app_type] => utility [patent_app_number] => 12/503373 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11787 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12503373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493155 [patent_doc_number] => 20100093667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'SALTS OF HIV INHIBITOR COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/499018 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14623 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093667.pdf [firstpage_image] =>[orig_patent_app_number] => 12499018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6549995 [patent_doc_number] => 20100016586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'THERAPEUTIC COMPOUNDS AND THEIR USE IN CANCER' [patent_app_type] => utility [patent_app_number] => 12/494917 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 130059 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016586.pdf [firstpage_image] =>[orig_patent_app_number] => 12494917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496614 [patent_doc_number] => 20090264642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Anhydrous crystal of bata-lactam compound and method for preparation thereof' [patent_app_type] => utility [patent_app_number] => 12/457746 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2745 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264642.pdf [firstpage_image] =>[orig_patent_app_number] => 12457746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474367 [patent_doc_number] => 20090247533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Ecteinascidins' [patent_app_type] => utility [patent_app_number] => 12/482753 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10393 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247533.pdf [firstpage_image] =>[orig_patent_app_number] => 12482753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398348 [patent_doc_number] => 20090318411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'PURINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/474613 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28748 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318411.pdf [firstpage_image] =>[orig_patent_app_number] => 12474613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469873 [patent_doc_number] => 08299051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Beta-lactamase inhibitory compounds' [patent_app_type] => utility [patent_app_number] => 12/463762 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32776 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12463762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5540010 [patent_doc_number] => 20090221815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'PROCESSES FOR THE PREPARATION OF CEPHEM DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/436619 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5606 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221815.pdf [firstpage_image] =>[orig_patent_app_number] => 12436619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232995 [patent_doc_number] => 08198434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Process for preparing cefsulodin sodium' [patent_app_type] => utility [patent_app_number] => 12/435462 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5960 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198434.pdf [firstpage_image] =>[orig_patent_app_number] => 12435462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398425 [patent_doc_number] => 08268802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Anti-proliferative compounds, compositions, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/436004 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34503 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12436004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558850 [patent_doc_number] => 20090270427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'PURINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/433388 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23441 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270427.pdf [firstpage_image] =>[orig_patent_app_number] => 12433388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496374 [patent_doc_number] => 20090264402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'NOVEL DIPHENYLAZETIDINONE SUBSTITUTED BY PIPERAZINE-1-SULFONIC ACID AND HAVING IMPROVED PHARMACOLOGICAL PROPERTIES' [patent_app_type] => utility [patent_app_number] => 12/432997 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8839 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264402.pdf [firstpage_image] =>[orig_patent_app_number] => 12432997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391686 [patent_doc_number] => 20090208999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Crystalline amoxicillin trihydrate powder' [patent_app_type] => utility [patent_app_number] => 12/385444 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9668 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208999.pdf [firstpage_image] =>[orig_patent_app_number] => 12385444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712787 [patent_doc_number] => 08093377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Cephalosporin in crystalline form' [patent_app_type] => utility [patent_app_number] => 12/416461 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3186 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093377.pdf [firstpage_image] =>[orig_patent_app_number] => 12416461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033873 [patent_doc_number] => 20110082293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'PROCESS FOR THE PREPARATION OF STERILE DORIPENEM' [patent_app_type] => utility [patent_app_number] => 12/934348 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1176 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082293.pdf [firstpage_image] =>[orig_patent_app_number] => 12934348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485799 [patent_doc_number] => 20090275564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH' [patent_app_type] => utility [patent_app_number] => 12/404413 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34376 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275564.pdf [firstpage_image] =>[orig_patent_app_number] => 12404413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386312 [patent_doc_number] => 20090227557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'SUBSTITUTED BETA-LACTAMS' [patent_app_type] => utility [patent_app_number] => 12/395813 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11807 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227557.pdf [firstpage_image] =>[orig_patent_app_number] => 12395813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343339 [patent_doc_number] => 20090181989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Purine Compunds as HSP90 Protein Inhibitors for the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 12/394891 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20173 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181989.pdf [firstpage_image] =>[orig_patent_app_number] => 12394891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628790 [patent_doc_number] => 20100004236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'PHOSPHODIESTERASE 4 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/393634 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26063 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004236.pdf [firstpage_image] =>[orig_patent_app_number] => 12393634 [rel_patent_id] =>[rel_patent_doc_number] =>)